|
1
|
Jiang HB, Yang TJ, Lu P and Ma YJ: Gene
expression profiling of gastric cancer. Eur Rev Med Pharmacol Sci.
18:2109–2115. 2014.PubMed/NCBI
|
|
2
|
Li T, Chen J, Liu QL, Huo ZH and Wang ZW:
Meta-analysis: E-cadherin immunoexpression as a potential prognosis
biomarker related to gastric cancer metastasis in Asian patients.
Eur Rev Med Pharmacol Sci. 18:2693–2703. 2014.PubMed/NCBI
|
|
3
|
Leung WK, Wu MS, Kakugawa Y, Kim JJ, Yeoh
KG, Goh KL, Wu KC, Wu DC, Sollano J, Kachintorn U, et al: Asia
Pacific Working Group on Gastric Cancer: Screening for gastric
cancer in Asia: Current evidence and practice. Lancet Oncol.
9:279–287. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Popiela T, Kulig J, Kolodziejczyk P and
Sierzega M: Polish Gastric Cancer Study Group: Long-term results of
surgery for early gastric cancer. Br J Surg. 89:1035–1042. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Forman D, Morris E, Eastwood A and
Kleijnen J: Guidelines for treatment of upper gastrointestinal
cancer. Lancet. 361:802003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang WH, Huang JQ, Zheng GF, Lam SK,
Karlberg J and Wong BC: Non-steroidal anti-inflammatory drug use
and the risk of gastric cancer: A systematic review and
meta-analysis. J Natl Cancer Inst. 95:1784–1791. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
McMillan DC: Systemic inflammation,
nutritional status and survival in patients with cancer. Curr Opin
Clin Nutr Metab Care. 12:223–226. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Schreiber RD, Old LJ and Smyth MJ: Cancer
immunoediting: Integrating immunity's roles in cancer suppression
and promotion. Science. 331:1565–1570. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Carruthers R, Tho LM, Brown J, Kakumanu S,
McCartney E and McDonald AC: Systemic inflammatory response is a
predictor of outcome in patients undergoing preoperative
chemoradiation for locally advanced rectal cancer. Colorectal Dis.
14:e701–707. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kemal Y, Demirağ G, Ekiz K and Yücel I:
Mean platelet volume could be a useful biomarker for monitoring
epithelial ovarian cancer. J Obstet Gynaecol. 34:515–518. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Seretis C, Seretis F, Lagoudianakis E,
Politou M, Gemenetzis G and Salemis NS: Enhancing the accuracy of
platelet to lymphocyte ratio after adjustment for large platelet
count: a pilot study in breast cancer patients. Int J Surg Oncol.
2012:6536082012.PubMed/NCBI
|
|
12
|
Celikbilek M, Dogan S, Ozbakır O, Zararsız
G, Kücük H, Gürsoy S, Yurci A, Güven K and Yücesoy M:
Neutrophil-lymphocyte ratio as a predictor of disease severity in
ulcerative colitis. J Clin Lab Anal. 27:72–76. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Imtiaz F, Shafique K, Mirza SS, Ayoob Z,
Vart P and Rao S: Neutrophil lymphocyte ratio as a measure of
systemic inflammation in prevalent chronic diseases in Asian
population. Int Arch Med. 5:22012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tousoulis D, Antoniades C, Koumallos N and
Stefanadis C: Pro-inflammatory cytokines in acute coronary
syndromes: From bench to bedside. Cytokine Growth Factor Rev.
17:225–233. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Walsh SR, Cook EJ, Goulder F, Justin TA
and Keeling NJ: Neutrophil-lymphocyte ratio as a prognostic factor
in colorectal cancer. J Surg Oncol. 91:181–184. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gwak MS, Choi SJ, Kim JA, Ko JS, Kim TH,
Lee SM, Park JA and Kim MH: Effects of gender on white blood cell
populations and neutrophil-lymphocyte ratio following gastrectomy
in patients with stomach cancer. J Korean Med Sci. 22(Suppl):
S104–S108. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sharaiha RZ, Halazun KJ, Mirza F, Port JL,
Lee PC, Neugut AI, Altorki NK and Abrams JA: Elevated preoperative
neutrophil: lymphocyte ratio as a predictor of postoperative
disease recurrence in esophageal cancer. Ann Surg Oncol.
18:3362–3369. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Thavaramara T, Phaloprakarn C,
Tangjitgamol S and Manusirivithaya S: Role of neutrophil to
lymphocyte ratio as a prognostic indicator for epithelial ovarian
cancer. J Med Assoc Thai. 94:871–877. 2011.PubMed/NCBI
|
|
19
|
Kemal Y, Yucel I, Ekiz K, Demirag G,
Yilmaz B, Teker F and Ozdemir M: Elevated serum neutrophil to
lymphocyte and platelet to lymphocyte ratios could be useful in
lung cancer diagnosis. Asian Pac J Cancer Prev. 15:2651–2654. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Azab B, Bhatt VR, Phookan J, Murukutla S,
Kohn N, Terjanian T and Widmann WD: Usefulness of the
neutrophil-to-lymphocyte ratio in predicting short- and long-term
mortality in breast cancer patients. Ann Surg Oncol. 19:217–224.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Proctor MJ, Morrison DS, Talwar D, Balmer
SM, Fletcher CD, O'Reilly DS, Foulis AK, Horgan PG and McMillan DC:
A comparison of inflammation-based prognostic scores in patients
with cancer. A Glasgow Inflammation Outcome Study. Eur J Cancer.
47:2633–2641. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Eisenhauer EA, Therasse P, Bogaerts J,
Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S,
Mooney M, et al: New response evaluation criteria in solid tumours:
Revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wu Y and Zhou BP: Inflammation: A driving
force speeds cancer metastasis. Cell Cycle. 8:3267–3273. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ilhan N, Ilhan N, Ilhan Y, Akbulut H and
Kucuksu M: C-reactive protein, procalcitonin, interleukin-6,
vascular endothelial growth factor and oxidative metabolites in
diagnosis of infection and staging in patients with gastric cancer.
World J Gastroenterol. 10:1115–1120. 2004.PubMed/NCBI
|
|
25
|
Lochhead P and El-Omar EM: Gastric cancer.
Br Med Bull. 85:87–100. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hussain SP and Harris CC: Inflammation and
cancer: an ancient link with novel potentials. Int J Cancer.
121:2373–2380. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Aliustaoglu M, Bilici A, Ustaalioglu BB,
Konya V, Gucun M, Seker M and Gumus M: The effect of peripheral
blood values on prognosis of patients with locally advanced gastric
cancer before treatment. Med Oncol. 27:1060–1065. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Smith RA, Bosonnet L, Raraty M, Sutton R,
Neoptolemos JP, Campbell F and Ghaneh P: Preoperative
platelet-lymphocyte ratio is an independent significant prognostic
marker in resected pancreatic ductal adenocarcinoma. Am J Surg.
197:466–472. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Raungkaewmanee S, Tangjitgamol S,
Manusirivithaya S, Srijaipracharoen S and Thavaramara T: Platelet
to lymphocyte ratio as a prognostic factor for epithelial ovarian
cancer. J Gynecol Oncol. 23:265–273. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Malik HZ, Prasad KR, Halazun KJ, Aldoori
A, Al-Mukhtar A, Gomez D, Lodge JP and Toogood GJ: Preoperative
prognostic score for predicting survival after hepatic resection
for colorectal liver metastases. Ann Surg. 246:806–814. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Heras P, Hatzopoulos A, Kritikos N and
Kritikos K: Platelet count and tumor progression in gastric cancer
patients. Scand J Gastroenterol. 45:1005–1006. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
De Larco JE, Wuertz BR and Furcht LT: The
potential role of neutrophils in promoting the metastatic phenotype
of tumors releasing interleukin-8. Clin Cancer Res. 10:4895–4900.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Neal CP, Mann CD, Sutton CD, Garcea G, Ong
SL, Steward WP, Dennison AR and Berry DP: Evaluation of the
prognostic value of systemic inflammation and socioeconomic
deprivation in patients with resectable colorectal liver
metastases. Eur J Cancer. 45:56–64. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Suzuki K, Kachala SS, Kadota K, Shen R, Mo
Q, Beer DG, Rusch VW, Travis WD and Adusumilli PS: Prognostic
immune markers in non-small cell lung cancer. Clin Cancer Res.
17:5247–5256. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lian L, Li W, Li ZY, Mao YX, Zhang YT,
Zhao YM, Chen K, Duan WM and Tao M: Inhibition of MCF-7 breast
cancer cell-induced platelet aggregation using a combination of
antiplatelet drugs. Oncol Lett. 5:675–680. 2013.PubMed/NCBI
|
|
36
|
Egan K, Crowley D, Smyth P, O'Toole S,
Spillane C, Martin C, Gallagher M, Canney A, Norris L, Conlon N, et
al: Platelet adhesion and degranulation induce pro-survival and
pro-angiogenic signalling in ovarian cancer cells. PLoS One.
6:e261252011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tsuruo T and Fujita N: Platelet
aggregation in the formation of tumor metastasis. Proc Jpn Acad,
Ser B, Phys Biol Sci. 84:189–198. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Camerer E, Qazi AA, Duong DN, Cornelissen
I, Advincula R and Coughlin SR: Platelets, protease-activated
receptors, and fibrinogen in hematogenous metastasis. Blood.
104:397–401. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jain S, Zuka M, Liu J, Russell S, Dent J,
Guerrero JA, Forsyth J, Maruszak B, Gartner TK, Felding-Habermann
B, et al: Platelet glycoprotein Ib alpha supports experimental lung
metastasis. Proc Natl Acad Sci USA. 104:9024–9028. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Klinger MH and Jelkmann W: Role of blood
platelets in infection and inflammation. J Interferon Cytokine Res.
22:913–922. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Alexandrakis MG, Passam FH, Moschandrea
IA, Christophoridou AV, Pappa CA, Coulocheri SA and Kyriakou DS:
Levels of serum cytokines and acute phase proteins in patients with
essential and cancer-related thrombocytosis. Am J Clin Oncol.
26:135–140. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Galizia GI, Lieto E, De Vita F, Romano C,
Orditura M, Castellano P, Imperatore V, Infusino S, Catalano G and
Pignatelli C: Circulating levels of interleukin-10 and
interleukin-6 in gastric and colon cancer patients before and after
surgery: relationship with radicality and outcome. J Interferon
Cytokine Res. 22:473–482. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Shariat SF, Andrews B, Kattan MW, Kim J,
Wheeler TM and Slawin KM: Plasma levels of interleukin-6 and its
soluble receptor are associated with prostate cancer progression
and metastasis. Urology. 58:1008–1015. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kim DK, Oh SY, Kwon HC, Lee S, Kwon KA,
Kim BG, Kim SG, Kim SH, Jang JS, Kim MC, et al: Clinical
significances of preoperative serum interleukin-6 and C-reactive
protein level in operable gastric cancer. BMC Cancer. 9:1552009.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Khandekar MM, Khurana AS, Deshmukh SD,
Kakrani AL, Katdare AD and Inamdar AK: Platelet volume indices in
patients with coronary artery disease and acute myocardial
infarction: An Indian scenario. J Clin Pathol. 59:146–149. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hurst NJ Jr, Najy AJ, Ustach CV, Movilla L
and Kim HR: Platelet-derived growth factor-C (PDGF-C) activation by
serine proteases: Implications for breast cancer progression.
Biochem J. 441:909–918. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Bambace NM and Holmes CE: The platelet
contribution to cancer progression. J Thromb Haemost. 9:237–249.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Ohashi R, Takahashi K, Miura K, Ishiwata
T, Sakuraba S and Fukuchi Y: Prognostic factors in patients with
inoperable non-small cell lung cancer - an analysis of long-term
survival patients. Gan To Kagaku Ryoho. 33:1595–1602.
2006.PubMed/NCBI
|
|
49
|
Milne K, Alexander C, Webb JR, Sun W,
Dillon K, Kalloger SE, Gilks CB, Clarke B, Köbel M and Nelson BH:
Absolute lymphocyte count is associated with survival in ovarian
cancer independent of tumor-infiltrating lymphocytes. J Transl Med.
10:332012. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Kobayashi N, Usui S, Kikuchi S, Goto Y,
Sakai M, Onizuka M and Sato Y: Preoperative lymphocyte count is an
independent prognostic factor in node-negative non-small cell lung
cancer. Lung Cancer. 75:223–227. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Ohtani H: Focus on TILs: Prognostic
significance of tumor infiltrating lymphocytes in human colorectal
cancer. Cancer Immun. 7:42007.PubMed/NCBI
|
|
52
|
Galon J, Costes A, Sanchez-Cabo F,
Kirilovsky A, Mlecnik B, Lagorce-Pagès C, Tosolini M, Camus M,
Berger A, Wind P, et al: Type, density, and location of immune
cells within human colorectal tumors predict clinical outcome.
Science. 313:1960–1964. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Mlecnik B, Tosolini M, Kirilovsky A,
Berger A, Bindea G, Meatchi T, Bruneval P, Trajanoski Z, Fridman
WH, Pagès F, et al: Histopathologic-based prognostic factors of
colorectal cancers are associated with the state of the local
immune reaction. J Clin Oncol. 29:610–618. 2011. View Article : Google Scholar : PubMed/NCBI
|
